Clinical Trials in Ohio

Showing 8021-8040 of 15,929 trials

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population

NCT04310566

This is a single-masked, crossover, randomized-controlled, dispensing clinical trial. A total of approximately 70 myopic eligible subjects will be targeted to complete the study.

Visual Acuity

Johnson & Johnson Vision Care, Inc.67 participantsStarted Feb 2020

Jacksonville, Florida, United States • Jacksonville, Florida, United States • Maitland, Florida, United States +4 more locations

COMPLETEDPhase 332 miles

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00369317

This phase III trial is studying how well combination chemotherapy works in treating young patients with Down syndrome and acute myeloid leukemia or myelodysplastic syndromes. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.

Childhood Acute Basophilic LeukemiaChildhood Acute Eosinophilic LeukemiaChildhood Acute Erythroleukemia (M6)+12 more

Children's Oncology Group205 participantsStarted Mar 2007

Phoenix, Arizona, United States • Downey, California, United States • Long Beach, California, United States +94 more locations

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Find Trials by Condition in Ohio

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

A Phase 2 Study of CIM331 for Atopic Dermatitis Patients

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Study of TV-1106 in Growth Hormone-Deficient Adults

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Cook IVC Filter Study

IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Argus® II Retinal Stimulation System Feasibility Protocol

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment